The Cost-Effectiveness of Subcutaneous Semaglutide Versus Empagliflozin in Type 2 Diabetes Uncontrolled on Metformin Alone in Denmark

INTRODUCTION: International and Danish guidelines recommend the use of glucagon-like peptide 1 receptor agonists (GLP-1 RA) and sodium–glucose cotransporter 2 (SGLT-2) inhibitors already in second line in the management of type 2 diabetes (T2D). The objective of this study was to evaluate the long-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehlers, Lars H., Lamotte, Mark, Ramos, Mafalda C., Sandgaard, Susanne, Holmgaard, Pia, Kristensen, Malene M., Ejskjaer, Niels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934846/
https://www.ncbi.nlm.nih.gov/pubmed/35187628
http://dx.doi.org/10.1007/s13300-022-01221-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934846/
https://www.ncbi.nlm.nih.gov/pubmed/35187628
http://dx.doi.org/10.1007/s13300-022-01221-3

Ejemplares similares